Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Southwest Cancer Care
mi
from
Escondido, CA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Southwest Cancer Care
mi
from
Escondido, CA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Monterey Bay Oncology
mi
from
Monterey, CA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Monterey Bay Oncology
mi
from
Monterey, CA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Ventura County Hematology Oncology Specialists
mi
from
Oxnard, CA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Eastern Colorado Health Care System - Denver VA
mi
from
Denver, CO
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Eastern Colorado Health Care System - Denver VA
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
George Washington University Medical Faculty Associates
mi
from
Washington,
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
George Washington University Medical Faculty Associates
mi
from
Washington,
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Advanced Medical Specialties
mi
from
Miami, FL
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Advanced Medical Specialties
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Pasco Pinellas Cancer Center
mi
from
New Port Richey, FL
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Pasco Pinellas Cancer Center
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Peachtree Hematology-Oncology Consultants
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Saint Louis Cancer Care LLP
mi
from
Bridgeton, MO
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Saint Louis Cancer Care LLP
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
MUSC Hollings Cancer Center
mi
from
Charleston, SC
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
MUSC Hollings Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Mary Crowley Cancer Center
mi
from
Dallas, TX
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Mary Crowley Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Baylor Charles A. Sammons
mi
from
Dallas, TX
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Baylor Charles A. Sammons
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Fort Worth
mi
from
Fort Worth, TX
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Seton Williamson
mi
from
Round Rock, TX
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Peninsula Cancer Institute
mi
from
Newport News, VA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Medical Oncology Associates
mi
from
Spokane, WA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Medical Oncology Associates
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Integrated Community Oncology Network, LLC
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists, PC
mi
from
Tualatin, OR
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists, PC
mi
from
Tualatin, OR
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Virginia Oncology Associates
mi
from
Newport News, VA
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Newport News, VA
Click here to add this to my saved trials
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated:  12/31/1969
Cross Cancer Institute
mi
from
Edmonton,
Phase 1 and 2 Study of PX-866 and Cetuximab
Phase 1/2 Study of PX-866 and Cetuximab
Status: Enrolling
Updated: 12/31/1969
Cross Cancer Institute
mi
from
Edmonton,
Click here to add this to my saved trials
Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)
RAD 1002: Phase I Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases
Status: Enrolling
Updated:  12/31/1969
Hazelrig-Salter Radiation Oncology Center/University of Alabama at Birmingham
mi
from
Birmingham, AL
Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)
RAD 1002: Phase I Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases
Status: Enrolling
Updated: 12/31/1969
Hazelrig-Salter Radiation Oncology Center/University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Phase II Study of Pasireotide LAR in Patients With Metastatic Neuroendocrine Carcinomas
Status: Enrolling
Updated:  12/31/1969
Stanford Cancer Institute
mi
from
Stanford, CA
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Phase II Study of Pasireotide LAR in Patients With Metastatic Neuroendocrine Carcinomas
Status: Enrolling
Updated: 12/31/1969
Stanford Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Phase II Study of Pasireotide LAR in Patients With Metastatic Neuroendocrine Carcinomas
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Phase II Study of Pasireotide LAR in Patients With Metastatic Neuroendocrine Carcinomas
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Brivanib Metastatic Renal Cell Carcinoma
Brivanib (BMS-582664, Brivanib Alaninate) in Treatment of Refractory Metastatic Renal Cell Carcinoma - A Phase II Pharmacodynamic and Baseline Biomarker Study
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Brivanib Metastatic Renal Cell Carcinoma
Brivanib (BMS-582664, Brivanib Alaninate) in Treatment of Refractory Metastatic Renal Cell Carcinoma - A Phase II Pharmacodynamic and Baseline Biomarker Study
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
Enhancement of Cetuximab-Induced Antibody-Dependent Cellular Cytotoxicity (ADCC) With Lenalidomide in Advanced Solid Tumors: A Phase I/IB Study
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
Enhancement of Cetuximab-Induced Antibody-Dependent Cellular Cytotoxicity (ADCC) With Lenalidomide in Advanced Solid Tumors: A Phase I/IB Study
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
18F-Fluoride PET Bone Scans Versus Traditional 99mTc-MDP Gamma Camera Bone Scans for the Diagnosis of Bone Metastases: a Blinded, Prospective Trial
Status: Enrolling
Updated:  12/31/1969
Seattle Nuclear Medicine
mi
from
Seattle, WA
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
18F-Fluoride PET Bone Scans Versus Traditional 99mTc-MDP Gamma Camera Bone Scans for the Diagnosis of Bone Metastases: a Blinded, Prospective Trial
Status: Enrolling
Updated: 12/31/1969
Seattle Nuclear Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
Denver Health Medical Center
mi
from
Denver, CO
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
Kettering Health Network
mi
from
Kettering, OH
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Kettering Health Network
mi
from
Kettering, OH
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences Universtiy Cancer Center
mi
from
Portland, OR
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences Universtiy Cancer Center
mi
from
Portland, OR
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated:  12/31/1969
Universidad Mayor de San Simon
mi
from
Cochabamba,
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics With Non-Small Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Universidad Mayor de San Simon
mi
from
Cochabamba,
Click here to add this to my saved trials
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
The Woodlands, TX
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
The Woodlands, TX
Click here to add this to my saved trials
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated:  12/31/1969
mi
from
Montreal,
A Phase 1b Trial in Patients With Renal Cell Cancer
A Phase 1b Study of LY573636-sodium in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Cancer
Status: Enrolling
Updated: 12/31/1969
mi
from
Montreal,
Click here to add this to my saved trials
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Epigenetically-Modified Autologous Tumor Cell Vaccines With ISCOMATRIX(TM) Adjuvant and Oral Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Epigenetically-Modified Autologous Tumor Cell Vaccines With ISCOMATRIX(TM) Adjuvant and Oral Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials